Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 16Lung Neoplasms 5Carcinoma, Ovarian Epithelial 5Carcinoma, Non-Small-Cell Lung 5Unspecified Adult Solid Tumor, Protocol Specific 4Squamous Cell Carcinoma of Head and Neck 4Rectal Neoplasms 4Prostatic Neoplasms 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Colorectal Neoplasms 4Colonic Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 4Breast Carcinoma In Situ 4Brain Neoplasms 4Sarcoma 3Liver Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Hepatocellular 3Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Pancreatic Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myeloid, Acute 2Leukemia 2Gliosarcoma 2Glioblastoma 2

Interventions

Cyclophosphamide 101Etoposide 60Carboplatin 55Vincristine 51Filgrastim 49Topotecan 44Temozolomide 44Melphalan 44Isotretinoin 44Doxorubicin 44Irinotecan 42Cisplatin 353-Iodobenzylguanidine 34Peripheral Blood Stem Cell Transplantation 31dinutuximab 30Granulocyte Colony-Stimulating Factor 30Radiotherapy 29sargramostim 28Granulocyte-Macrophage Colony-Stimulating Factor 25Busulfan 22Magnetic Resonance Spectroscopy 19aldesleukin 18Thiotepa 18fludarabine 17Interleukin-2 17humanized 3F8 anti-GD2 monoclonal antibody 16etoposide phosphate 16naxitamab 15Ifosfamide 15Biopsy 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroblastoma × Mass Spectrometry × Clear all
NCT01387724 2016-05-18

Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma

Children's Oncology Group

Completed
300 enrolled
CNS

Neuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡